SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-055905
Filing Date
2019-11-12
Accepted
2019-11-12 08:11:11
Documents
1
Period of Report
2019-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3690
  Complete submission text file 0001209191-19-055905.txt   5062
Mailing Address 1301 SECOND AVE., SUITE 4200 SEATTLE WA 98101
Business Address
LASEZKAY GEORGE M (Reporting) CIK: 0001020514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 191206284

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations